Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Defactinib |
Trade Name | |
Synonyms | VS-6063|PF-04554878 |
Drug Descriptions |
Defactinib (VS-6063) inhibits FAK, resulting in decreased downstream signaling, and potentially leading to reduced tumor cell proliferation and survival (PMID: 31739184). |
DrugClasses | FAK inhibitor 13 |
CAS Registry Number | 1073154-85-4 |
NCIT ID | C79809 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Defactinib + Paclitaxel | Carboplatin Defactinib Paclitaxel | 0 | 0 |
Defactinib | Defactinib | 0 | 7 |
Defactinib + Gemcitabine + Pembrolizumab | Defactinib Gemcitabine Pembrolizumab | 0 | 1 |
Defactinib + Pembrolizumab | Defactinib Pembrolizumab | 0 | 2 |
Defactinib + RO5126766 | Defactinib RO5126766 | 0 | 4 |
Defactinib + Trametinib | Defactinib Trametinib | 0 | 0 |
Defactinib + VS-5584 | Defactinib VS-5584 | 0 | 1 |